NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $10.53 +0.13 (+1.25 %) (As of 05/21/2019 04:00 PM ET)Previous Close$10.40Today's Range$10.41 - $10.655052-Week Range$8.54 - $14.97Volume1.86 million shsAverage Volume2.24 million shsMarket Capitalization$1.75 billionP/E Ratio19.15Dividend YieldN/ABeta1.29 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company operates in two segments, Clinical and Financial Solutions and Population Health. The Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related software, connectivity and coordinated care solutions, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. The Population Health segment offers health management, and financial management and patient engagement solutions to hospitals, health systems, accountable care organizations, and other care facilities. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois. Receive MDRX News and Ratings via Email Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer integrated systems design Sub-IndustryHealth Care Technology SectorMedical Current SymbolNASDAQ:MDRX Previous Symbol CUSIP01988P10 CIK1124804 Webhttp://www.allscripts.com/ Phone800-334-8534Debt Debt-to-Equity Ratio0.59 Current Ratio1.04 Quick Ratio1.04Price-To-Earnings Trailing P/E Ratio19.15 Forward P/E Ratio21.94 P/E Growth2.1 Sales & Book Value Annual Sales$1.75 billion Price / Sales1.00 Cash Flow$1.7609 per share Price / Cash Flow5.98 Book Value$8.75 per share Price / Book1.20Profitability EPS (Most Recent Fiscal Year)$0.55 Net Income$412.33 million Net Margins20.60% Return on Equity6.92% Return on Assets2.39%Miscellaneous Employees9,500 Outstanding Shares166,438,000Market Cap$1.75 billion Next Earnings Date8/1/2019 (Estimated) OptionableOptionable Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions What is Allscripts Healthcare Solutions' stock symbol? Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX." How will Allscripts Healthcare Solutions' stock buyback program work? Allscripts Healthcare Solutions declared that its board has initiated a stock repurchase plan on Thursday, August 2nd 2018, which permits the company to repurchase $250,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 11.3% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its shares are undervalued. How were Allscripts Healthcare Solutions' earnings last quarter? Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its earnings results on Thursday, May, 2nd. The software maker reported $0.16 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.14 by $0.02. The software maker earned $432 million during the quarter, compared to the consensus estimate of $436.47 million. Allscripts Healthcare Solutions had a return on equity of 6.92% and a net margin of 20.60%. The firm's quarterly revenue was down .4% on a year-over-year basis. During the same period last year, the firm posted $0.16 earnings per share. View Allscripts Healthcare Solutions' Earnings History. When is Allscripts Healthcare Solutions' next earnings date? Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for Allscripts Healthcare Solutions. What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings? Allscripts Healthcare Solutions updated its FY19 earnings guidance on Thursday, May, 2nd. The company provided earnings per share guidance of $0.65 to $0.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.67. Allscripts Healthcare Solutions also updated its FY 2019 guidance to $0.65-0.70 EPS. What price target have analysts set for MDRX? 9 analysts have issued 12-month target prices for Allscripts Healthcare Solutions' stock. Their predictions range from $10.00 to $16.00. On average, they expect Allscripts Healthcare Solutions' share price to reach $13.2857 in the next year. This suggests a possible upside of 26.2% from the stock's current price. View Analyst Price Targets for Allscripts Healthcare Solutions. What is the consensus analysts' recommendation for Allscripts Healthcare Solutions? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allscripts Healthcare Solutions. What are Wall Street analysts saying about Allscripts Healthcare Solutions stock? Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock: 1. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on MDRX shares and maintain our price target at $10, After the market close on Thursday, May 2, MDRX reported 1Q19 results, with revenue slightly below our estimate. 1Q19 bookings increased 9% y/y. MDRX reiterated its 2019 guidance for non-GAAP EPS and bookings. The company continues its policy of not providing full year revenue guidance, but provided 2Q19 revenue guidance, which was below our estimate but in line with FactSet consensus. We note the company had previously provided a modest three-year CAGR outlook." (5/2/2019) 2. According to Zacks Investment Research, "Allscripts continues to gain from its Software, Delivery, Support and Maintenance units, which delivered solid growth in the last couple of quarters. Significant growth in bookings also buoys optimism. The company’s growth in revenue cycle services along with the recently-closed acquisition of HealthGrid is likely to boost its FollowMyHealth patient engagement platform. Apart from these, management is optimistic about the collaboration with Microsoft made in the recent past. On the flip side, the company’s core Client Services unit has reported dismal performance in recent times. Also, Allscripts saw significant margin contraction in the last reported quarter. The company is exposed to integration risks. Intense competition in the niche space is an added concern. Over the past year, Allscripts has underperformed its industry." (4/24/2019) Has Allscripts Healthcare Solutions been receiving favorable news coverage? Media stories about MDRX stock have trended somewhat negative on Tuesday, according to InfoTrie Sentiment. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Allscripts Healthcare Solutions earned a media sentiment score of -1.2 on InfoTrie's scale. They also assigned media stories about the software maker a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. Are investors shorting Allscripts Healthcare Solutions? Allscripts Healthcare Solutions saw a increase in short interest in April. As of April 15th, there was short interest totalling 20,675,861 shares, an increase of 8.4% from the March 29th total of 19,078,421 shares. Based on an average daily volume of 1,566,012 shares, the short-interest ratio is currently 13.2 days. Approximately 12.4% of the company's shares are sold short. View Allscripts Healthcare Solutions' Current Options Chain. Who are some of Allscripts Healthcare Solutions' key competitors? Some companies that are related to Allscripts Healthcare Solutions include Caci International (CACI), Science Applications International (SAIC), Verint Systems (VRNT), NetScout Systems (NTCT), Scientific Games (SGMS), Ebix (EBIX), Nextgen Healthcare (NXGN), Sykes Enterprises (SYKE), Tufin Software Technologies (TUFN), Digimarc (DMRC), Onespan (OSPN), KEYW (KEYW), Ribbon Communications (RBBN), Pareteum (TEUM) and Agilysys (AGYS). What other stocks do shareholders of Allscripts Healthcare Solutions own? Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Starbucks (SBUX), Walgreens Boots Alliance (WBA), Electronic Arts (EA), Nuance Communications (NUAN), AK Steel (AKS), Bausch Health Companies (BHC), Twitter (TWTR) and Autodesk (ADSK). Who are Allscripts Healthcare Solutions' key executives? Allscripts Healthcare Solutions' management team includes the folowing people: Mr. Paul M. Black, CEO & Director (Age 61)Mr. Richard J. Poulton, Pres (Age 54)Mr. Dennis M. Olis, Chief Financial Officer (Age 56)Mr. Brian P. Farley, Exec. VP, Gen. Counsel, Corp. Sec. & Chief Admin. Officer (Age 49)Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 52) Who are Allscripts Healthcare Solutions' major shareholders? Allscripts Healthcare Solutions' stock is owned by many different of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (5.56%), Neuberger Berman Group LLC (1.88%), Northern Trust Corp (1.59%), Geode Capital Management LLC (1.56%), Fort Washington Investment Advisors Inc. OH (0.90%) and Jacobs Levy Equity Management Inc. (0.86%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View Institutional Ownership Trends for Allscripts Healthcare Solutions. Which institutional investors are selling Allscripts Healthcare Solutions stock? MDRX stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Fort Washington Investment Advisors Inc. OH, Royce & Associates LP, Dimensional Fund Advisors LP, Marshall Wace LLP, BNP Paribas Arbitrage SA, Hennessy Advisors Inc. and Dupont Capital Management Corp. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, Dennis Olis and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions. Which institutional investors are buying Allscripts Healthcare Solutions stock? MDRX stock was purchased by a variety of institutional investors in the last quarter, including Alambic Investment Management L.P., Penn Capital Management Co. Inc., Man Group plc, Neuberger Berman Group LLC, GAM Holding AG, SEI Investments Co, Dynamic Technology Lab Private Ltd and Peregrine Capital Management LLC. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Michael Klayko, Paul Black and Yancey L Spruill. View Insider Buying and Selling for Allscripts Healthcare Solutions. How do I buy shares of Allscripts Healthcare Solutions? Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Allscripts Healthcare Solutions' stock price today? One share of MDRX stock can currently be purchased for approximately $10.53. How big of a company is Allscripts Healthcare Solutions? Allscripts Healthcare Solutions has a market capitalization of $1.75 billion and generates $1.75 billion in revenue each year. The software maker earns $412.33 million in net income (profit) each year or $0.55 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,500 workers across the globe. What is Allscripts Healthcare Solutions' official website? The official website for Allscripts Healthcare Solutions is http://www.allscripts.com/. How can I contact Allscripts Healthcare Solutions? Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected] MarketBeat Community Rating for Allscripts Healthcare Solutions (NASDAQ MDRX)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 565 (Vote Outperform)Underperform Votes: 584 (Vote Underperform)Total Votes: 1,149MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/21/2019 by MarketBeat.com StaffFeatured Article: Relative Strength Index Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.